The single-arm trial focuses on the therapy’s efficacy and safety in NF1 subjects with plexiform neurofibromas. Credit: S_L/Shutterstock. Healx has dosed the first subject in the open-label Phase II ...

Mission Statement: Evidence-based Complementary and Alternative Medicine (eCAM) is an international, peer-reviewed journal that seeks to understand the sources and to encourage rigorous research ...